BMT Clinical Trial Network at Stanford

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies Pathology

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Hodgkin lymphoma Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Leukaemia Non-Hodgkin lymphoma

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies Pathology

Gary Gilliland

Cancer Center Support grant (comprehensive)

Hodgkin lymphoma Non-Hodgkin lymphoma Leukaemia

Gregory Armstrong

Childhood Cancer Survivor Study

Non-Hodgkin lymphoma Hodgkin lymphoma Leukaemia

Pediatric oncology or childhood cancer

Global Noncommunicable Diseases Intiatives

Improvement of Health-Related Quality of Life for Children with Leukemia and Lymphoma in Georgia

Leukaemia

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Leukaemia Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology